Treatment of Androgenetic Alopecia Using PRP to Target Dysregulated Mechanisms and Pathways
Open Access
- 16 March 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 843127
Abstract
Androgenetic alopecia (“AGA”) is the most prevalent type of progressive hair loss, causing tremendous psychological and social stress in patients. However, AGA treatment remains limited in scope. The pathogenesis of androgenetic alopecia is not completely understood but is known to involve a hair follicle miniaturization process in which terminal hair is transformed into thinner, softer vellus-like hair. This process is related to the dysregulation of the Wnt/β-catenin signaling pathway, which causes premature termination of the anagen growth phase in hair follicles. Historically used for wound healing, platelet rich plasma (“PRP”) has recently been at the forefront of potential AGA treatment. PRP is an autologous preparation of plasma that contains a high number of platelets and their associated growth factors such as EGF, IGF-1, and VEGF. These factors are known to individually play important roles in regulating hair follicle growth. However, the clinical effectiveness of PRP is often difficult to characterize and summarize as there are wide variabilities in the PRP preparation and administration protocols with no consensus on which protocol provides the best results. This study follows the previous review from our group in 2018 by Cervantes et al. to analyze and discuss recent clinical trials using PRP for the treatment of AGA. In contrast to our previous publication, we include recent clinical trials that assessed PRP in combination or in direct comparison with standard of care procedures for AGA such as topical minoxidil and/or oral finasteride. Overall, this study aims to provide an in-depth analysis of PRP in the treatment of AGA based on the evaluation of 17 recent clinical trials published between 2018 and October 2021. By closely examining the methodologies of each clinical trial included in our study, we additionally aim to provide an overall consensus on how PRP can be best utilized for the treatment of AGA.Keywords
This publication has 111 references indexed in Scilit:
- Hematological and hepatic effects of vascular epidermal growth factor (VEGF) used to stimulate hair growth in an animal modelBMC Dermatology, 2013
- Adenovirus-Mediated Wnt5a Expression Inhibits the Telogen-To-Anagen Transition of Hair Follicles in MiceInternational Journal of Medical Sciences, 2013
- Dermal β-catenin activity in response to epidermal Wnt ligands is required for fibroblast proliferation and hair follicle initiationDevelopment, 2012
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human DiseasesAdvances in Urology, 2011
- β-catenin Activity in the Dermal Papilla Regulates Morphogenesis and Regeneration of HairDevelopmental Cell, 2010
- KGF and EGF signalling block hair follicle induction and promote interfollicular epidermal fate in developing mouse skinDevelopment, 2009
- Keratinocyte Growth Inhibition through the Modification of Wnt Signaling by Androgen in Balding Dermal Papilla CellsThe Journal of Clinical Endocrinology & Metabolism, 2009
- Integration of Estrogen and Wnt Signaling Circuits by the Polycomb Group Protein EZH2 in Breast Cancer CellsMolecular and Cellular Biology, 2007
- Scratching the surface of skin developmentNature, 2007
- Platelet-Rich Plasma (PRP): What Is PRP and What Is Not PRP?Implant Dentistry, 2001